• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Terbina Teva
    / Teva Israel LTD, Israel


    Active Ingredient
    Terbinafine 250 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    14 X 250 mg

    not in the basket chart 25803 20303

    Dosage

    Please refer to the license holder for further details.


    Indications

    Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidermophyton floccosum. Oral Terbinafine should only be used to treat extensive, severe ringworm infections (tinea corporis, tinea cruris and tinea pedis).
    Oral Terbinafine is not effective against vaginal candidiasis or pityriasis (tinea) versicolor.Onychomycoses ( tinea unguium, ringworm of the nails) due to infection with dermatophyte organisms ( hyphomycetes


    Contra-Indications

    Please refer to the license holder for further details.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Manufacturer
    Teva Israel Ltd

    סרגל נגישות

    CLOSE